Logo image of CCEP

COCA-COLA EUROPACIFIC PARTNE (CCEP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CCEP - GB00BDCPN049 - Common Stock

92.33 USD
+0.64 (+0.7%)
Last: 12/1/2025, 6:15:14 PM
92.33 USD
0 (0%)
After Hours: 12/1/2025, 6:15:14 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCEP. CCEP was compared to 33 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. While showing a medium growth rate, CCEP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
Each year in the past 5 years CCEP has been profitable.
Each year in the past 5 years CCEP had a positive operating cash flow.
CCEP Yearly Net Income VS EBIT VS OCF VS FCFCCEP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of CCEP (4.83%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 19.11%, CCEP is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Return On Invested Capital of CCEP (7.78%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CCEP is below the industry average of 11.60%.
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROIC 7.78%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP Yearly ROA, ROE, ROICCCEP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of CCEP (7.35%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CCEP has declined.
CCEP's Operating Margin of 11.13% is in line compared to the rest of the industry. CCEP outperforms 42.42% of its industry peers.
In the last couple of years the Operating Margin of CCEP has declined.
CCEP has a worse Gross Margin (35.20%) than 84.85% of its industry peers.
CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP Yearly Profit, Operating, Gross MarginsCCEP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
CCEP has more shares outstanding than it did 1 year ago.
CCEP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP Yearly Shares OutstandingCCEP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP Yearly Total Debt VS Total AssetsCCEP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.09. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
CCEP's Altman-Z score of 2.09 is in line compared to the rest of the industry. CCEP outperforms 54.55% of its industry peers.
The Debt to FCF ratio of CCEP is 6.04, which is on the high side as it means it would take CCEP, 6.04 years of fcf income to pay off all of its debts.
CCEP has a better Debt to FCF ratio (6.04) than 60.61% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that CCEP has dependencies on debt financing.
CCEP has a worse Debt to Equity ratio (1.26) than 75.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Altman-Z 2.09
ROIC/WACC1.01
WACC7.69%
CCEP Yearly LT Debt VS Equity VS FCFCCEP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP's Current ratio of 0.83 is on the low side compared to the rest of the industry. CCEP is outperformed by 75.76% of its industry peers.
CCEP has a Quick Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CCEP (0.65) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.65
CCEP Yearly Current Assets VS Current LiabilitesCCEP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CCEP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
CCEP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.80% yearly.
Looking at the last year, CCEP shows a quite strong growth in Revenue. The Revenue has grown by 9.04% in the last year.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%

3.2 Future

Based on estimates for the next years, CCEP will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.72% on average per year.
The Revenue is expected to grow by 3.34% on average over the next years.
EPS Next Y4.31%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
EPS Next 5Y8.72%
Revenue Next Year2.1%
Revenue Next 2Y2.44%
Revenue Next 3Y2.93%
Revenue Next 5Y3.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCEP Yearly Revenue VS EstimatesCCEP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CCEP Yearly EPS VS EstimatesCCEP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.92, CCEP is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as CCEP.
CCEP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.57, CCEP is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCEP is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CCEP to the average of the S&P500 Index (36.21), we can say CCEP is valued rather cheaply.
Industry RankSector Rank
PE 23.92
Fwd PE 17.57
CCEP Price Earnings VS Forward Price EarningsCCEP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEP is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CCEP is valued a bit cheaper than the industry average as 75.76% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.23
EV/EBITDA 13.78
CCEP Per share dataCCEP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.55
PEG (5Y)4.12
EPS Next 2Y6.48%
EPS Next 3Y7.12%

5

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.55%.
CCEP's Dividend Yield is a higher than the industry average which is at 3.06.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.55%

5.2 History

On average, the dividend of CCEP grows each year by 9.91%, which is quite nice.
CCEP has paid a dividend for at least 10 years, which is a reliable track record.
CCEP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP Yearly Dividends per shareCCEP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

60.89% of the earnings are spent on dividend by CCEP. This is not a sustainable payout ratio.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP60.89%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
CCEP Yearly Income VS Free CF VS DividendCCEP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP Dividend Payout.CCEP Dividend Payout, showing the Payout Ratio.CCEP Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

NASDAQ:CCEP (12/1/2025, 6:15:14 PM)

After market: 92.33 0 (0%)

92.33

+0.64 (+0.7%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-05 2025-11-05
Earnings (Next)N/A N/A
Inst Owners37.34%
Inst Owner Change5.49%
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap41.92B
Revenue(TTM)20.88B
Net Income(TTM)1.53B
Analysts77.27
Price Target102.17 (10.66%)
Short Float %3.03%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield 2.55%
Yearly Dividend2.29
Dividend Growth(5Y)9.91%
DP60.89%
Div Incr Years4
Div Non Decr Years4
Ex-Date11-14 2025-11-14 (1.43)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.02%
PT rev (3m)0.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.12%
EPS NY rev (3m)-0.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 23.92
Fwd PE 17.57
P/S 1.74
P/FCF 18.23
P/OCF 12.39
P/B 4.51
P/tB N/A
EV/EBITDA 13.78
EPS(TTM)3.86
EY4.18%
EPS(NY)5.25
Fwd EY5.69%
FCF(TTM)5.06
FCFY5.49%
OCF(TTM)7.45
OCFY8.07%
SpS53.21
BVpS20.45
TBVpS-22.8
PEG (NY)5.55
PEG (5Y)4.12
Graham Number42.15
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROCE 10.52%
ROIC 7.78%
ROICexc 8.57%
ROICexgc 51.16%
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
FCFM 9.52%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexgc growth 3Y8.99%
ROICexgc growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Debt/EBITDA 3.08
Cap/Depr 98.22%
Cap/Sales 4.49%
Interest Coverage 9.37
Cash Conversion 89.23%
Profit Quality 129.6%
Current Ratio 0.83
Quick Ratio 0.65
Altman-Z 2.09
F-Score6
WACC7.69%
ROIC/WACC1.01
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
EPS Next Y4.31%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
EPS Next 5Y8.72%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%
Revenue Next Year2.1%
Revenue Next 2Y2.44%
Revenue Next 3Y2.93%
Revenue Next 5Y3.34%
EBIT growth 1Y2.97%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.74%
EBIT Next 3Y17.22%
EBIT Next 5Y12.38%
FCF growth 1Y5.8%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y13.11%
OCF growth 3Y13.08%
OCF growth 5Y9.96%

COCA-COLA EUROPACIFIC PARTNE / CCEP FAQ

Can you provide the ChartMill fundamental rating for COCA-COLA EUROPACIFIC PARTNE?

ChartMill assigns a fundamental rating of 4 / 10 to CCEP.


Can you provide the valuation status for COCA-COLA EUROPACIFIC PARTNE?

ChartMill assigns a valuation rating of 3 / 10 to COCA-COLA EUROPACIFIC PARTNE (CCEP). This can be considered as Overvalued.


How profitable is COCA-COLA EUROPACIFIC PARTNE (CCEP) stock?

COCA-COLA EUROPACIFIC PARTNE (CCEP) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for CCEP stock?

The Price/Earnings (PE) ratio for COCA-COLA EUROPACIFIC PARTNE (CCEP) is 23.92 and the Price/Book (PB) ratio is 4.51.


What is the earnings growth outlook for COCA-COLA EUROPACIFIC PARTNE?

The Earnings per Share (EPS) of COCA-COLA EUROPACIFIC PARTNE (CCEP) is expected to grow by 4.31% in the next year.